Related references
Note: Only part of the references are listed.Developmental co-regulation of the β and γ GABAA receptor subunits with distinct α subunits in the human dorsolateral prefrontal cortex
Stu G. Fillman et al.
INTERNATIONAL JOURNAL OF DEVELOPMENTAL NEUROSCIENCE (2010)
Prefrontal GABAA receptor α-subunit expression in normal postnatal human development and schizophrenia
Carlotta E. Duncan et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2010)
Amyloid-β-induced neuronal dysfunction in Alzheimer's disease: from synapses toward neural networks
Jorge J. Palop et al.
NATURE NEUROSCIENCE (2010)
Synaptic Depression and Aberrant Excitatory Network Activity in Alzheimer's Disease: Two Faces of the Same Coin?
Jorge J. Palop et al.
NEUROMOLECULAR MEDICINE (2010)
Senile myoclonic epilepsy: Delineation of a common condition associated with Alzheimer's disease in Down syndrome
Roberto De Simone et al.
SEIZURE-EUROPEAN JOURNAL OF EPILEPSY (2010)
HOW IMPORTANT IS ALZHEIMER'S DISEASE AS A RISK FACTOR FOR UNPROVOKED SEIZURES AND EPILEPSY IN THE ELDERLY?
Bassel W. Abou-Khalil
EPILEPSY CURRENTS (2010)
Epilepsy and Cognitive Impairments in Alzheimer Disease
Jorge J. Palop et al.
ARCHIVES OF NEUROLOGY (2009)
A Critical Period in Cortical Interneuron Neurogenesis in Down Syndrome Revealed by Human Neural Progenitor Cells
Anita Bhattacharyya et al.
DEVELOPMENTAL NEUROSCIENCE (2009)
GABAergic interneurons targeting dendrites of pyramidal cells in the CA1 area of the hippocampus
Thomas Klausberger
EUROPEAN JOURNAL OF NEUROSCIENCE (2009)
Excitatory-Inhibitory Relationship in the Fascia Dentata in the Ts65Dn Mouse Model of Down Syndrome
Pavel V. Belichenko et al.
JOURNAL OF COMPARATIVE NEUROLOGY (2009)
Amyloid β-Induced Neuronal Hyperexcitability Triggers Progressive Epilepsy
Rimante Minkeviciene et al.
JOURNAL OF NEUROSCIENCE (2009)
An immunohistochemical study of GABAA receptor gamma subunits in Alzheimer's disease hippocampus: Relationship to neurofibrillary tangle progression
Masahiko Iwakiri et al.
NEUROPATHOLOGY (2009)
GABA(A) receptors: Subtypes provide diversity of function and pharmacology
Richard W. Olsen et al.
NEUROPHARMACOLOGY (2009)
RO4938581, a novel cognitive enhancer acting at GABAA α5 subunit-containing receptors
Theresa M. Ballard et al.
PSYCHOPHARMACOLOGY (2009)
Amyloid beta peptides and glutamatergic synaptic dysregulation
Kodeeswaran Parameshwaran et al.
EXPERIMENTAL NEUROLOGY (2008)
Etazolate, a neuroprotective drug linking GABAA receptor pharmacology to amyloid precursor protein processing
M. Marcade et al.
JOURNAL OF NEUROCHEMISTRY (2008)
International union of pharmacology.: LXX.: Subtypes of γ-aminobutyric AcidA receptors:: Classification on the basis of subunit composition, pharmacology, and function.: Update
Richard W. Olsen et al.
PHARMACOLOGICAL REVIEWS (2008)
Alterations in GABA-related transcriptome in the dorsolateral prefrontal cortex of subjects with schizophrenia
T. Hashimoto et al.
MOLECULAR PSYCHIATRY (2008)
GABAA receptors in aging and Alzheimer's disease
Robert A. Rissman et al.
JOURNAL OF NEUROCHEMISTRY (2007)
Synaptic and cognitive abnormalities in mouse models of down syndrome: Exploring genotype-phenotype relationships
Pavel V. Belichenko et al.
JOURNAL OF COMPARATIVE NEUROLOGY (2007)
Aberrant excitatory neuronal activity and compensatory remodeling of inhibitory hippocampal circuits in mouse models of Alzheimer's disease
Jorge J. Palop et al.
NEURON (2007)
An inverse agonist selective for α5 subunit-containing GABAA receptors enhances cognition
GR Dawson et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2006)
Age-related alterations in GABAA receptor subunits in the nonhuman primate hippocampus
RA Rissman et al.
BRAIN RESEARCH (2006)
GABAA receptor γ subunits in the hippocampus of the rat after perforant pathway lesion
M Iwakiri et al.
NEUROSCIENCE LETTERS (2006)
GABA-based therapeutic approaches:: GABAA receptor subtype functions
U Rudolph et al.
CURRENT OPINION IN PHARMACOLOGY (2006)
Chronic stimulation of GABAA receptor with muscimol reduces amyloid β protein (25-35)-induced neurotoxicity in cultured rat cortical cells
BY Lee et al.
NEUROSCIENCE RESEARCH (2005)
Down syndrome, Alzheimer's disease and seizures
M Menéndez
BRAIN & DEVELOPMENT (2005)
Presynaptic, extrasynaptic and axonal GABA(A) receptors in the CNS: where and why?
DM Kullmann et al.
PROGRESS IN BIOPHYSICS & MOLECULAR BIOLOGY (2005)
GABAA receptors:: building the bridge between subunit mRNAs, their promoters, and cognate transcription factors
JL Steiger et al.
PHARMACOLOGY & THERAPEUTICS (2004)
Taurine prevents the neurotoxicity of β-amyloid and glutamate receptor agonists:: activation of GABA receptors and possible implications for Alzheimer's disease and other neurological disorders
PR Louzada et al.
FASEB JOURNAL (2004)
Molecular mechanisms of glutamate-dependent neurodegeneration in ischemia and traumatic brain injury
M Arundine et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2004)
Biochemical and molecular studies of NMDA receptor subunits NR1/2A/2B in hippocampal subregions throughout progression of Alzheimer's disease pathology
AJ Mishizen-Eberz et al.
NEUROBIOLOGY OF DISEASE (2004)
Hippocampal long-term potentiation suppressed by increased inhibition in the Ts65Dn mouse, a genetic model of Down syndrome
AM Kleschevnikov et al.
JOURNAL OF NEUROSCIENCE (2004)
Differential preservation of AMPA receptor subunits in the hippocampi of Alzheimer's disease patients according to Braak stage
TL Carter et al.
EXPERIMENTAL NEUROLOGY (2004)
Neuroprotection by D-securinine against neurotoxicity induced by beta-amyloid (25-35)
L Xu et al.
NEUROLOGICAL RESEARCH (2004)
Plasticity of glutamate and GABAA receptors in the hippocampus of patients with Alzheimer's disease
DM Armstrong et al.
CELLULAR AND MOLECULAR NEUROBIOLOGY (2003)
GABA-A receptor subtypes in the brain: a paradigm for CNS drug discovery?
PJ Whiting
DRUG DISCOVERY TODAY (2003)
Activation of muscarinic receptors inhibits β-amyloid peptide-induced signaling in cortical slices
ZL Gu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Biochemical analysis of GABA(A) receptor subunits alpha 1, alpha 5, beta 1, beta 2 in the hippocampus of patients with Alzheimer's disease neuropathology
RA Rissman et al.
NEUROSCIENCE (2003)
GABA(C) Receptors as Drug Targets
Graham A. R. Johnston et al.
CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS (2003)
International Union of Pharmacology.: XXXIII.: Mammalian γ-aminobutyric acidB receptors:: Structure and function
NG Bowery et al.
PHARMACOLOGICAL REVIEWS (2002)
On the cause of mental retardation in Down syndrome: extrapolation from full and segmental trisomy 16 mouse models
Z Galdzicki et al.
BRAIN RESEARCH REVIEWS (2001)
Differences between GABA levels in Alzheimer's disease and Down syndrome with Alzheimer-like neuropathology
R Seidl et al.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2001)
Age-related loss of the AMPA receptor subunits GluR2/3 in the human nucleus basalis of Meynert
MD Ikonomovic et al.
EXPERIMENTAL NEUROLOGY (2000)
GABAA and α-amino-3-hydroxy-5-methylsoxazole-4-propionate receptors are differentially affected by aging in the rat hippocampus
D Ruano et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
GABA(A) receptors: Immunocytochemical distribution of 13 subunits in the adult rat brain
S Pirker et al.
NEUROSCIENCE (2000)
Density and pharmacology of alpha 5 subunit-containing GABA(A) receptors are preserved in hippocampus of Alzheimer's disease patients
O Howell et al.
NEUROSCIENCE (2000)
Share Paper
